Hydmoxia

Hydmoxia

hydroxycarbamide

Manufacturer:

Deva Holding

Distributor:

American Taiwan Biopharm

Marketer:

American Taiwan Biopharm
Basic Prescribing Info
Contents
Hydroxycarbamide
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01XX05 - hydroxycarbamide ; Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.
Presentation/Packing
Form
Hydmoxia cap 500 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in